Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: A conversation between aging researchers and FDA regulators

Shalender Bhasin, Mark A. Espeland, William J. Evans, Luigi Ferrucci, Linda P. Fried, Thomas M. Gill, Marco Pahor, Stephanie Studenski, Jack Guralnik, Susan Nayfield, Sergei Romashkin, Robert Perlstein, Laurie Burke, Mary Parks

Research output: Contribution to journalReview article

Original languageEnglish (US)
Pages (from-to)487-491
Number of pages5
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume64
Issue number4
DOIs
StatePublished - Apr 1 2009

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Bhasin, S., Espeland, M. A., Evans, W. J., Ferrucci, L., Fried, L. P., Gill, T. M., Pahor, M., Studenski, S., Guralnik, J., Nayfield, S., Romashkin, S., Perlstein, R., Burke, L., & Parks, M. (2009). Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: A conversation between aging researchers and FDA regulators. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 64(4), 487-491. https://doi.org/10.1093/gerona/gln042